Hailing Lu

3.2k total citations
63 papers, 2.4k citations indexed

About

Hailing Lu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Hailing Lu has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 27 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in Hailing Lu's work include Immunotherapy and Immune Responses (31 papers), T-cell and B-cell Immunology (12 papers) and Immune Response and Inflammation (11 papers). Hailing Lu is often cited by papers focused on Immunotherapy and Immune Responses (31 papers), T-cell and B-cell Immunology (12 papers) and Immune Response and Inflammation (11 papers). Hailing Lu collaborates with scholars based in United States, United Kingdom and Italy. Hailing Lu's co-authors include Mary L. Disis, Ekram Gad, Vivian Goodell, Abbi L. Engel, Yushe Dang, Gregory E. Holt, Yi Yang, Keith L. Knutson, Lucio G. Costa and Marina Guizzetti and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Hailing Lu

61 papers receiving 2.4k citations

Peers

Countries citing papers authored by Hailing Lu

Since Specialization

Citations

This map shows the geographic impact of Hailing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailing Lu more than expected).

Fields of papers citing papers by Hailing Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hailing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailing Lu. The network helps show where Hailing Lu may publish in the future.

Co-authorship network of co-authors of Hailing Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hailing Lu. A scholar is included among the top collaborators of Hailing Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hailing Lu. Hailing Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1 2019 ·Clinical Cancer Research ·Neeta Somaiah, Matthew S. Block, Joseph W. Kim, Geoffrey I. Shapiro, T. Khanh, Patrick Hwu, Joseph P. Eder, Robin L. Jones, Hailing Lu, Jan H. ter Meulen, Chet Bohac, Michael Chen, Frank J. Hsu, Sacha Gnjatic, Seth M. Pollack	71
2	Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets 2019 ·Vaccine ·Sasha E. Stanton, Ekram Gad, (unknown), Hailing Lu, Mary L. Disis	16
3	Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma 2018 ·Clinical Cancer Research ·Shailender Bhatia, Natalie J. Miller, Hailing Lu, (unknown), Dafina Ibrani, Michi M. Shinohara, David R. Byrd, Upendra Parvathaneni, Rima M. Kulikauskas, Jan ter Meulen, Frank J. Hsu, David M. Koelle, Paul Nghiem	103
4	A phase 2 study of CMB305 and atezolizumab in NY-ESO-1+ soft tissue sarcoma: Interim analysis of immunogenicity, tumor control and survival 2017 ·Annals of Oncology ·Sant P. Chawla, Brian A. Van Tine, Seth M. Pollack, Kristen N. Ganjoo, Anthony Elias, Richard F. Riedel, Steven Attia, Edwin Choy, Scott H. Okuno, Mark Agulnik, Margaret von Mehren, Michael B. Livingston, (unknown), Claire F. Verschraegen, T Philip, Chet Bohac, Hailing Lu, (unknown), Robert G. Maki	12
5	The TLR2 agonist in polysaccharide-K is a structurally distinct lipid which acts synergistically with the protein-bound β-glucan 2014 ·Journal of Natural Medicines ·(unknown), (unknown), Leanna J. Standish, Hailing Lu	14
6	TLR Agonists for Cancer Immunotherapy: Tipping the Balance between the Immune Stimulatory and Inhibitory Effects 2014 ·Frontiers in Immunology ·Hailing Lu	70
7	Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer 2014 ·Journal of Translational Medicine ·Jianning Mao, Jon J. Ladd, Ekram Gad, (unknown), Melissa M. Johnson, (unknown), Jennifer S. Childs, Hailing Lu, Yushe Dang, Elizabeth K. Broussard, Sasha E. Stanton, Samir Hanash, Mary L. Disis	20
8	Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant 2013 ·Immunobiology ·Abbi L. Engel, (unknown), Ekram Gad, (unknown), (unknown), Yi Yang, Yushe Dang, Mary L. Disis, Hailing Lu	28
9	VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC 2011 ·Clinical Cancer Research ·Hailing Lu, Gregory N. Dietsch, (unknown), Yi Yang, Smita Ghanekar, Margaret Inokuma, Maria Suni, Vernon C. Maino, Katherine Henderson, James Jeffry Howbert, Mary L. Disis, Robert M. Hershberg	134
10	TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy 2011 ·Clinical Cancer Research ·Hailing Lu, Yi Yang, Ekram Gad, Carol Inatsuka, Cynthia A. Wenner, Mary L. Disis, Leanna J. Standish	71
11	The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system 2011 ·Expert Review of Clinical Pharmacology ·Abbi L. Engel, Gregory E. Holt, Hailing Lu	163
12	Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells 2010 ·Clinical Cancer Research ·Hailing Lu, Yi Yang, Ekram Gad, Cynthia A. Wenner, Amy Chang, Emily R. Larson, Yushe Dang, Mark R. Martzen, Leanna J. Standish, Mary L. Disis	125
13	Treatment Failure of a TLR-7 Agonist Occurs Due to Self-Regulation of Acute Inflammation and Can Be Overcome by IL-10 Blockade 2010 ·The Journal of Immunology ·Hailing Lu, Wolfgang Wagner, Ekram Gad, Yi Yang, (unknown), Lynn M. Amon, (unknown), Emily R. Larson, Amy Chang, (unknown), Mary L. Disis	64
14	Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer 2007 ·Expert Opinion on Therapeutic Targets ·Hailing Lu, Vivian Goodell, Mary L. Disis	23
15	The Tumor Antigen Repertoire Identified in Tumor-Bearing Neu Transgenic Mice Predicts Human Tumor Antigens 2006 ·Cancer Research ·Hailing Lu, Keith L. Knutson, Ekram Gad, Mary L. Disis	49
16	IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in neu -Transgenic Mice 2006 ·The Journal of Immunology ·Keith L. Knutson, Yushe Dang, Hailing Lu, Jason Lukas, Bond Almand, Ekram Gad, (unknown), Mary L. Disis	99
17	Interleukin-7 improves reconstitution of antiviral CD4 T cells 2005 ·Biology of Blood and Marrow Transplantation ·Hailing Lu, Zhuo Zhao, Tomáš Kalina, Hans‐Peter Kiem, Jan Storek	2
18	Interleukin-7 improves reconstitution of antiviral CD4 T cells 2004 ·Clinical Immunology ·Hailing Lu, Zhao Zhao, Tomáš Kalina, Thurman Gillespy, Denny Liggitt, Robert G. Andrews, David G. Maloney, Hans‐Peter Kiem, Jan Storek	18
19	Intracellular signal transduction pathways as targets for neurotoxicants 2001 ·Toxicology ·Lucio G. Costa, Marina Guizzetti, Hailing Lu, F. Bordi, Annabella Vitalone, B. Tita, Maura Palmery, P. Valeri, Bruno Silvestrini	24
20	Activation of mitogen‐activated protein kinase by muscarinic receptors in astroglial cells: Role in DNA synthesis and effect of ethanol 2001 ·Glia ·Kevin Yagle, Hailing Lu, Marina Guizzetti, Thomas Möller, Lucio G. Costa	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact